Smith & Nephew Plc Director Declaration (1856S)
04 Novembre 2019 - 2:07PM
UK Regulatory
TIDMSN.
RNS Number : 1856S
Smith & Nephew Plc
04 November 2019
4 November 2019
Smith & Nephew plc
DIRECTOR DECLARATION
In accordance with Listing Rule 9.6.14 R the Company announces
that Roland Diggelmann, Chief Executive Officer of Smith &
Nephew plc, has been appointed as Director of the Board of
Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc. is listed
on NASDAQ (Nasdaq: AXDX).
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RDNUGGAUGUPBGWC
(END) Dow Jones Newswires
November 04, 2019 08:07 ET (13:07 GMT)
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Apr 2023 a Apr 2024